Is Venous Thromboembolism a Chronic Inflammatory Disease?

被引：19
作者：
Piazza, Gregory [1 ]
Ridker, Paul M. [1 ,2 ]
机构：
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, Boston, MA 02115 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Cardiovasc Dis Prevent,Dept Med, Boston, MA 02115 USA
来源：
CLINICAL CHEMISTRY | 2015年 / 61卷 / 02期
关键词：
RHEUMATOID-ARTHRITIS; LONG-TERM; THROMBOSIS; RISK; PREVENTION; ROSUVASTATIN; RATIONALE; DURATION; THERAPY; EVENTS;
D O I：
10.1373/clinchem.2014.234088
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：313 / 316
页数：4
相关论文
共 20 条
[1]   Intertwining of thrombosis and inflammation in atherosclerosis [J].
Croce, Kevin ;
Libby, Peter .
CURRENT OPINION IN HEMATOLOGY, 2007, 14 (01) :55-61
[2]   Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis [J].
Dessein, PH ;
Joffe, BI ;
Singh, S .
ARTHRITIS RESEARCH & THERAPY, 2005, 7 (03) :R634-R643
[3]   Rationale and design of the Cardiovascular Inflammation Reduction Trial: A test of the inflammatory hypothesis of atherothrombosis [J].
Everett, Brendan M. ;
Pradhan, Aruna D. ;
Solomon, Daniel H. ;
Paynter, Nina ;
MacFadyen, Jean ;
Zaharris, Elaine ;
Gupta, Milan ;
Clearfield, Michael ;
Libby, Peter ;
Hasan, Ahmed A. K. ;
Glynn, Robert J. ;
Ridker, Paul M. .
AMERICAN HEART JOURNAL, 2013, 166 (02) :199-+
[4]   C-reactive protein and venous thromboembolism A prospective investigation in the ARIC cohort [J].
Folsom, Aaron R. ;
Lutsey, Pamela L. ;
Astor, Brad C. ;
Cushman, Mary .
THROMBOSIS AND HAEMOSTASIS, 2009, 102 (04) :615-619
[5]   A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism [J].
Glynn, Robert J. ;
Danielson, Eleanor ;
Fonseca, Francisco A. H. ;
Genest, Jacques ;
Gotto, Antonio M., Jr. ;
Kastelein, John J. P. ;
Koenig, Wolfgang ;
Libby, Peter ;
Lorenzatti, Alberto J. ;
MacFadyen, Jean G. ;
Nordestgaard, Borge G. ;
Shepherd, James ;
Willerson, James T. ;
Ridker, Paul M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (18) :1851-1861
[6]   Optimal Duration of Anticoagulation After Venous Thromboembolism [J].
Goldhaber, Samuel Z. ;
Piazza, Gregory .
CIRCULATION, 2011, 123 (06) :664-667
[7]   Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients [J].
Hjeltnes, G. ;
Hollan, I. ;
Forre, O. ;
Wiik, A. ;
Mikkelsen, K. ;
Agewall, S. .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2011, 40 (06) :422-427
[8]   Risk of Venous Thromboembolism in Patients With Rheumatoid Arthritis and Association With Disease Duration and Hospitalization [J].
Holmqvist, Marie E. ;
Neovius, Martin ;
Eriksson, Jonas ;
Mantel, Angla ;
Wallberg-Jonsson, Solveig ;
Jacobsson, Lennart T. H. ;
Askling, Johan .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (13) :1350-1356
[9]   Increased Rheumatoid Factor and Deep Venous Thrombosis: 2 Cohort Studies of 54628 Individuals from the General Population [J].
Meyer-Olesen, Christine L. ;
Nielsen, Sune F. ;
Nordestgaard, Borge G. .
CLINICAL CHEMISTRY, 2015, 61 (02) :349-359
[10]   Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study [J].
Nielsen, Sune F. ;
Bojesen, Stig E. ;
Schnohr, Peter ;
Nordestgaard, Borge G. .
BMJ-BRITISH MEDICAL JOURNAL, 2012, 345
12